Flaxman, A, Marchevsky, NG, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ, Folegatti, PM, Fowler, J, Hill, AVS, Kerridge, S et al, Minassian, AM, Mongkolsapaya, J, Mujadidi, YF, Plested, E, Ramasamy, MN, Robinson, H, Sanders, H, Sheehan, E, Smith, H, Snape, MD, Song, R, Woods, D, Screaton, G, Gilbert, SC, Voysey, M, Pollard, AJ, Lambe, T, Oxford COVID Vaccine Trial group, and Tahmasebi, F (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Voysey, M, Costa Clemens, SA, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Clutterbuck, EA, Collins, AM, Cutland, CL, Darton, TC, Dheda, K, Dold, C, Duncan, CJA et al, Emary, KRW, Ewer, KJ, Flaxman, A, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Galiza, E, Goodman, AL, Green, CM, Green, CA, Greenland, M, Hill, C, Hill, HC, Hirsch, I, Izu, A, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Libri, V, Lillie, PJ, Marchevsky, NG, Marshall, RP, Mendes, AVA, Milan, EP, Minassian, AM, McGregor, A, Mujadidi, YF, Nana, A, Padayachee, SD, Phillips, DJ, Pittella, A, Plested, E, Pollock, KM, Ramasamy, MN, Ritchie, AJ, Robinson, H, Schwarzbold, AV, Smith, A, Song, R, Snape, MD, Sprinz, E, Sutherland, RK, Thomson, EC, Török, ME, Toshner, M, Turner, DPJ, Vekemans, J, Villafana, TL, White, T, Williams, CJ, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ, Aban, M, Abeyskera, KWM, Aboagye, J, Adam, M, Adams, K, Adamson, JP, Adewatan, G, Adlou, S, Ahmed, K, Akhalwaya, Y, Akhalwaya, S, Alcock, A, Ali, A, Allen, ER, Allen, L, Alvernaz, FB, Amorim, FS, Andrade, CS, Andritsou, F, Anslow, R and Tahmasebi, F (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736